1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Diabetic foot

Granulox for managing chronic non-healing wounds

Medtech innovation briefing [MIB296] Published: 10 May 2022

  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Patient organisation comments
  • Expert commentators
  • Development of this briefing
Download (PDF)

Advice

  • Next

Regulatory information

Regulatory information

Granulox is a CE-marked class III medical device.


  • Next